Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobramycin Sonic Aerosol for Chronic Rhinosinusitis in Cystic Fibrosis
NCT02888730Phase 3Terminated
- Start
- Feb 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tobramycin in chronic rhinosinusitis (CRS). Started Feb 2017; status: terminated.
02
Drugs
tobramycin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT02888730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02888730.